Pfizer Inc (PFIZ34) — Cash Flow Reinvestment Rate
Pfizer Inc (PFIZ34) has a Cash Flow Reinvestment Rate of 0.63x as of March 2026, reinvesting R$1.64 Billion (capex R$436.00 Million plus investments R$1.20 Billion) from operating cash flow of R$2.62 Billion. Check cash flow quality index of Pfizer Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pfizer Inc Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Pfizer Inc across 12 annual periods. Explore PFIZ34 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Pfizer Inc (2014–2025)
Year-by-year capital reinvestment analysis for Pfizer Inc. For live market cap and broader valuation context, see PFIZ34 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (BRL) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | R$4.36 Billion | R$11.71 Billion | R$2.63 Billion | ▼ -14.7% |
| 2024 | 0.44x | R$5.56 Billion | R$12.74 Billion | R$2.91 Billion | ▼ -82.2% |
| 2023 | 2.45x | R$29.56 Billion | R$12.04 Billion | R$3.86 Billion | ▲ +624.3% |
| 2022 | 0.34x | R$9.92 Billion | R$29.27 Billion | R$3.24 Billion | ▼ -50.3% |
| 2021 | 0.68x | R$22.23 Billion | R$32.58 Billion | R$2.71 Billion | ▲ +120.2% |
| 2020 | 0.31x | R$4.46 Billion | R$14.40 Billion | R$2.79 Billion | ▼ -67.2% |
| 2019 | 0.95x | R$11.90 Billion | R$12.59 Billion | R$2.59 Billion | ▲ +73.4% |
| 2018 | 0.55x | R$8.63 Billion | R$15.83 Billion | R$2.20 Billion | ▲ +107.7% |
| 2017 | 0.26x | R$4.41 Billion | R$16.80 Billion | R$2.22 Billion | ▼ -56.7% |
| 2016 | 0.61x | R$9.81 Billion | R$16.19 Billion | R$2.00 Billion | ▼ -44.5% |
| 2015 | 1.09x | R$16.04 Billion | R$14.69 Billion | R$1.40 Billion | ▲ +244.0% |
| 2014 | 0.32x | R$5.42 Billion | R$17.08 Billion | R$1.20 Billion | — |